Viewing Study NCT04308395

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:15 PM
Ignite Modification Date: 2026-02-02 @ 7:44 AM
Study NCT ID: NCT04308395
Status: TERMINATED
Last Update Posted: 2024-09-24
First Post: 2020-03-11
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)
Sponsor: Sol-Gel Technologies, Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Basal Cell Nevus Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gorlin syndrome View
None Patidegib View
None Basal cell nevus syndrome View
None Nevoid basal cell carcinoma syndrome View
None Basal cell carcinoma View
None Hedgehog View
None Surgically eligible basal cell carcinomas View
None BCC View
None BCNS View